Category: Research Updates

Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS (sanofi.com)

Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS Paris, February 15, 2024. The…

Stuart Schlossman